Insulet (PODD) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.66
- EPS estimate
- $1.45
- EPS surprise
- +14.26%
- Revenue surprise
- +1.82%
- Revenue
- $801.7M
- Revenue estimate
- $787.4M
- Reported
- Aug 5, 2026
Insulet reported Q2 2026 results on August 5, 2026. Earnings per share were $1.66, ahead of the $1.45 estimate by 14.26%. Revenue was $801.7 million, a 1.82% beat on the $787.4 million consensus. Compared with Q2 2025, EPS rose about 42% from $1.17 and revenue rose about 23.5% from $649.1 million.
The longer record shows fast growth from a low base. Insulet posted losses in Q2 2022, at $0.50 per share, and Q3 2022, at $0.08, leaving 2022 EPS at just $0.06. Annual EPS then rose to $2.91 in 2023, $3.33 in 2024 and $4.98 in 2025, about 50% more than the year before. Annual revenue grew about 59% from 2023 to 2025. The first half of 2026 totals $3.08 per share, about 41% above the same period of 2025. Q2 2026 set the highs in the table for both EPS and revenue. Over the last 20 quarters, Insulet beat the EPS estimate 16 times. The most recent miss was Q2 2024, at 2.43% below.
Insulet reported Q3 results between November 2 and November 7 in each of the past five years. That points to early November 2026 for the next report. It will show whether the year-over-year growth continues.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | $1.45 | $1.66 | +14.26% | $801.7M | SEC |
| Q1 2026 | May 6, 2026 | $1.20 | $1.42 | +18.46% | $761.7M | SEC |
| Q4 2025 | Feb 18, 2026 | $1.46 | $1.55 | +6.04% | $783.8M | SEC |
| Q3 2025 | Nov 6, 2025 | $1.14 | $1.24 | +8.75% | $706.3M | SEC |
| Q2 2025 | Aug 7, 2025 | $0.92 | $1.17 | +27.20% | $649.1M | SEC |
| Q1 2025 | May 8, 2025 | $0.79 | $1.02 | +29.11% | $569.0M | SEC |
| Q4 2024 | Feb 20, 2025 | $1.00 | $1.15 | +14.59% | $597.5M | SEC |
| Q3 2024 | Nov 7, 2024 | $0.78 | $0.90 | +15.73% | $543.9M | SEC |
| Q2 2024 | Aug 8, 2024 | $0.56 | $0.55 | −2.43% | $488.5M | SEC |
| Q1 2024 | May 9, 2024 | $0.40 | $0.73 | +81.95% | $441.7M | SEC |
| Q4 2023 | Feb 22, 2024 | $0.65 | $1.44 | +120.52% | $509.8M | SEC |
| Q3 2023 | Nov 2, 2023 | $0.40 | $0.74 | +83.62% | $432.7M | SEC |
| Q2 2023 | Aug 8, 2023 | $0.26 | $0.39 | +48.57% | $396.5M | SEC |
| Q1 2023 | May 4, 2023 | $0.11 | $0.34 | +219.85% | $358.1M | SEC |
| Q4 2022 | Feb 23, 2023 | $0.22 | $0.24 | +9.44% | $369.7M | SEC |
| Q3 2022 | Nov 3, 2022 | $0.15 | −$0.08 | −152.60% | $340.8M | SEC |
| Q2 2022 | Aug 4, 2022 | $0.22 | −$0.50 | −322.62% | $299.4M | SEC |
| Q1 2022 | May 5, 2022 | $0.23 | $0.40 | +72.41% | $295.4M | SEC |
| Q4 2021 | Feb 23, 2022 | $0.31 | $0.42 | +33.93% | $307.7M | SEC |
| Q3 2021 | Nov 4, 2021 | $0.25 | $0.18 | −27.42% | $275.6M | SEC |
Quarterly revenue
Frequently asked questions
When did Insulet (PODD) last report earnings?
Insulet last reported on Aug 5, 2026, covering fiscal Q2 2026.
Did PODD beat earnings estimates?
Yes. Insulet reported EPS of $1.66 for Q2 2026 against a $1.45 estimate — a 14.26% beat.
How much revenue did PODD report last quarter?
Insulet reported $801.7M in revenue for Q2 2026, against a consensus estimate of $787.4M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.